ArisGlobal is a leading global provider of innovative SaaS software solutions, which are transforming the way the most successful life sciences companies handle drug safety, clinical development, regulatory compliance, and medical affairs.

ArisGlobal is a visionary technology company that has successfully developed a next-generation platform that uses advanced cognitive computing and machine learning to automate all core functions of drug safety, regulatory compliance and medical affairs. It is headquartered in Miami, Florida, USA, with regional offices in Europe, India, Japan and China.

Benefiting from deep expertise, longstanding customer relationships and a 30-year track record, ArisGlobal assists clients in maintaining regulatory compliance, managing and mitigating risk, and improving operational efficiency. Currently, more than 200 life sciences companies such as AstraZeneca, NovoNordisk, Merck and Novartis, CROs and government health authorities, as well as 40 of the top 50 global biopharmaceutical companies, rely on ArisGlobal’s solutions.

As a leading healthcare and technology investor, Nordic Capital will further support and accelerate ArisGlobal’s continued growth and development.


Sector Icon

Tech & Payments

Sector Icon


Key Information

Revenues Icon

Revenues 2021*

EUR 110 million

Employees Icon



Ownership Icon


Nordic Capital Fund IX and Nordic Capital Fund X, controlling shareholding

Head Office Icon

Head office

Miami, FL, USA

Investment Icon

Investment date